Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

U.S. Biotech/Pharma Sector Daily Observations Letter: March 22, 2018 [Seeking Alpha]

Reata Pharmaceuticals, Inc. - Class A (RETA) 
Last reata pharmaceuticals, inc. - class a earnings: 2/19 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.reatapharma.com
Company Research Source: Seeking Alpha
U.S. Biotech/Pharma Sector Daily Observations Letter: March 22, 2018SummaryA retest of February’s lows in major market indexes has become more likely.We examine the possible reasons why Reata Pharmaceuticals (RETA) stock did not respond well to today's successful phase 2 data.Could the benefits of Reata's compound Bardoxolone methyl be obtained by olive oil or garlic? Show less Read more
Impact Snapshot
Event Time:
RETA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RETA alerts
Opt-in for
RETA alerts

from News Quantified
Opt-in for
RETA alerts

from News Quantified